Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • dbrg77
    Junior Member
    • Sep 2010
    • 6

    #1

    Why using short reads?

    Hi, everyone. I'm a newbie here.

    I have a question that always baffles me that why NGS only uses short sequence tags?

    Instead sequence the whole DNA fragments, it only sequences the first 25-50 bp of a DNA fragment.

    Is there a particular reason for doing this?

    Thank you!
  • krobison
    Senior Member
    • Nov 2007
    • 734

    #2
    It's what the technology is capable of. Most technologies attain their signal from a clonal population of DNA molecules which are signalling in sync; as this synchronization is lost (dephasing) the noise climbs; eventually noise overwhelms signal. The best review on this is in The challenges of sequencing by synthesis., whose author list features many of the heavy hitters in the field.

    PacBio's SMRT technology (and Helicos' before it) looks at single molecules and therefore does not have a dephasing problem. For PacBio, the problem is apparently that the laser used to observe the sequencing eventually destroys the DNA polymerase that is doing the work, probably via a free radical mechanism. I don't know if Helicos ever figured out what kept their reads very short.

    Note that short is not quite as short these days; SOLiD is getting around 75bp and Illumina on the order of 150 bp. 454 routinely gets 400+ (perhaps soon out to 800) and PacBio 1.5Kb. Still, all sorts of blue sky proposals are aiming at reads of 10s or perhaps 100s or even 1000s of kilobases.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    16 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    21 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-13-2026, 09:56 AM
    0 responses
    22 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-09-2026, 11:14 AM
    0 responses
    27 views
    0 reactions
    Last Post SEQadmin2  
    Working...